NEW YORK, April 6 - LI-COR Biosciences will expand its sales, distribution, and support services into the UK, the company said Friday.
The move comes after a decision to end a sales and support agreement with MWG-Biotech, which was formerly responsible for selling and servicing LI-COR's laboratory instruments in the UK and parts of Europe. The agreement ended because MWG plans to concentrate on its own product line, a LI-COR spokesman said.
LI-COR's instruments for genomics research include DNA sequencers and an infrared system for fluorescent detection of nucleic acids in Western blots.
The UK subsidiary will open at the end of April, said the spokeman, at an undisclosed location.
LI-COR's agreement with MWG expires at the end of the year, but LI-COR will incrementally begin to sell its own products until then. Upon opening, the company's UK subsidiary will begin selling its infrared detection system, called Odyssey.
"MWG and LI-COR have had a mutually beneficial relationship since 1992 and in the UK since 1998," Larry Middendorf, president of LI-COR, said in a statement. "Both companies are committed to a smooth transition in order to ensure that customer service and support are provided at the high standards that our mutual customers deserve and expect."
Last year, LI-COR of Lincoln, Nebraska, opened a subsidiary in Frankfurt to support the company's European distributors and will begin selling DNA sequencers after July.